ASTCT Applauds FDA Approval of Axatilimab-Csfr for the Treatment of Chronic Graft-Versus-Host Disease (cGVHD)
CHICAGO, IL / ACCESSWIRE / August 15, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT) applauds the U.S. Food and Drug Administration’s (FDA) approval of axatilimab-csfr (Niktimvo,…
